Regulation - Pricing, Nephrology and Hepatology

Filter

Popular Filters

Added benefit of Mitsubishi Tanabe's colestilan not proven, says German IQWiG

10-07-2013

In an early benefit assessment under the Act on the Reform of the Market for Medicinal Products (AMNOG),…

BindRencolestilanEuropeMitsubishi TanabeNephrology and HepatologyPharmaceuticalPricingRegulation

Affymax and Takeda get special Medicare code for Omontys

16-04-2012

USA-based Affymax (Nasdaq: AFFY) and the US subsidiary of Japanese drug major Takeda Pharmaceuticals…

AffymaxBiotechnologyNephrology and HepatologyNorth AmericaOmontysOncologypeginesatidePharmaceuticalPricingRegulationTakeda Pharmaceuticals

Back to top